1
Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition(s):Polycystic Kidney DiseaseLast Updated:February 11, 2019Completed
Niacinamide: 560 Clinical Trials, Page 1 of 56
Hide Studies Not Open or Pending
2
Study of Niacin in Glioblastoma
Condition(s):Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeLast Updated:June 22, 2021Recruiting
3
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition(s):Polycystic Kidney DiseaseLast Updated:December 1, 2016Completed
4
Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus
Condition(s):Cutaneous Lupus Erythematosus; Systemic Lupus Erythematosus RashLast Updated:February 2, 2021Active, not recruiting
5
Nicotinamide for Prevention of Pre-malignant Actinic Keratosis in Kidney Transplant Recipients
Condition(s):Actinic KeratosesLast Updated:April 22, 2021Completed
6
Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients
Condition(s):Mitochondrial MyopathiesLast Updated:June 4, 2019Completed
7
Study of Nicotinamide in Early Onset Preeclampsia
Condition(s):PreeclampsiaLast Updated:September 25, 2020Recruiting
8
The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects
Condition(s):Heart FailureLast Updated:October 28, 2020Terminated
9
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:January 22, 2020Completed
10
Short-term Effect of Extended-release Niacin on Endothelial Function.
Condition(s):HypoalphalipoproteinemiaLast Updated:September 13, 2013Completed